Halliburton Co (HAL)
Bolsas y Mercados Argentinos · Argentina · prices in ARS · close of 27 Oct 2026
Key indicators
| Last close | ARS 29,380.00 |
|---|---|
| 52-week range | 17,500.00 – 32,260.00 |
| Return, 1 month / 3 months | +11.0% / +15.2% |
| Return, 1 year / 3 years | +59.1% / +82.0% |
| Trend | Uptrend |
| RSI (14) | 67 |
| Volatility (1 year) | 40.3% |
| Worst drawdown (1 year) | -22.8% |
| Average daily value traded | 52.37M ARS |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Halliburton is an oilfield services company based in Houston, Texas. It supplies equipment and technical services used to drill and complete oil and gas wells, including cementing, stimulation, drilling fluids and completion tools. Its customers are energy producers and drilling contractors operating in oil and gas fields around the world. The company also offers software and consulting support for reservoir evaluation and well construction, helping operators plan and carry out their field work.
On this site Halliburton Co appears as a stock on the Bolsas y Mercados Argentinos (Argentina), code HAL, with prices in Argentine pesos (ARS). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Halliburton Co (HAL) trades on the Bolsas y Mercados Argentinos in Argentina. It last closed at ARS 29,380.00 on 27 October 2026.
Its price-based Market X-Ray is 58 out of 100 (a fair price profile), ranking 63 of 154 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 59.1% and over the last three months it rose 15.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Bolsas y Mercados Argentinos
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 59 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 8.4% | ||
| From 52-week high | -8.6% | ||
| Momentum | 68 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 15.2% | ||
| 6-month return | -2.9% | ||
| 12-month return, skipping the last month | 43.3% | ||
| Stability (higher is calmer) | 58 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 40.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.8% | ||
| Liquidity | 40 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 52.37M ARS | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +7.3% |
|---|---|
| 1 month | +11.0% |
| 3 months | +15.2% |
| 6 months | −2.9% |
| 1 year | +59.1% |
| 3 years | +82.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 27,573.79 / 27,103.91 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 816.41 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Sep 2026 | USD 128.9875 |
| 3 Jun 2026 | USD 128.5625 |
| 4 Mar 2026 | USD 121.2525 |
| 3 Dec 2025 | USD 120.1900 |
| 3 Sep 2025 | USD 123.7600 |
| 4 Jun 2025 | USD 115.4300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Bolsas y Mercados Argentinos; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.